COMBINATION THERAPY OF MOUSE LEUKEMIA L1210 BY 1-BETA -D-ARABINOFURANOSYLCYTOSINE AND 6-((4-NITROBENZYL)THIO)-9-BETA -D-RIBOFURANOSYLPURINE = TRAITEMENT D'ASSOCIATION DE LA LEUCEMIE L1210 DE LA SOURIS PAR LE 1-BETA -D-ARABINOFURANOSYLCYTOSINE (ARA-C) ET LA ((NITRO-4 BENZYL)THIO)-6-BETA -D-RIBOFURANOSYL-9 PURINE (NBMPR)CASS CE; HUONG MUZIK; PATERSON ARP et al.1975; CANCER RES.; U.S.A.; DA. 1975; VOL. 35; NO 5; PP. 1187-1193; BIBL. 39REF.Article

INTERFERENCE OF 6-MERCAPTOPURINE RIBOSIDE, 6-METHYL-MERCAPTOPURINE RIBOSIDE AND AZATHIOPRINE WITH THE MORPHOGENETIC DIFFERENTIATION OF MOUSE EXTREMITIES IN VIVO AND IN ORGAN CULTURE.NEUBERT D; LESSMOLLMANN U; HINZ N et al.1977; ARCH. (NAUNYN-SCHMIEDEBERG'S) PHARMACOL.; GERM.; DA. 1977; VOL. 298; NO 2; PP. 93-105; BIBL. 29 REF.Article

EFFECTS OF LEVAMISOLE ADMINISTRATION ON TREATMENT WITH 6-MERCAPTOPURINE RIBOSIDE OF MICE BEARING L1210 LEUKEMIA CELLSMIURA T; NOGIWA E; KURASHIGE S et al.1980; CANCER RES.; ISSN 0008-5472; USA; DA. 1980; VOL. 40; NO 12; PP. 4813-4816; BIBL. 25 REF.Article

The absorption of 6-mercaptopurine from 6-mercaptopuyrine riboside in rat small intestine : effect of phosphatePENNINGTON, A. M; BRONK, J. R.Cancer chemotherapy and pharmacology. 1995, Vol 36, Num 2, pp 136-142, issn 0344-5704Article

Dose-response relationships of rat fetal skeleton variations: Relevance for risk assessmentCHAHOUD, Ibrahim; PAUMGARTTEN, Francisco J. R.Environmental research (New York, N.Y. : Print). 2009, Vol 109, Num 7, pp 922-929, issn 0013-9351, 8 p.Article